期刊文献+

果糖胺与血糖、糖化血红蛋白的关系研究 被引量:8

Association among Fructosamine and Blood Glucose,Glycated Hemoglobin
原文传递
导出
摘要 目的探讨果糖胺(fructosamine,FMN)与血糖、糖化血红蛋白(HbA1c)的关系。方法 2009年5月-2009年8月,以75例糖尿病患者作为糖尿病组,36例健康志愿者作为正常对照组,进行口服糖耐量试验,检测其空腹血糖及餐后2h血糖水平,并同时检测FMN与HbA1c水平。结果糖尿病组空腹血糖、餐后2h血糖、FMN、HbA1c均高于正常对照组(P<0.05)。FMN与HbA1c、空腹血糖、餐后2h血糖均呈正相关关系(P<0.05)。FMN与空腹血糖的相关系数高于HbA1c与空腹血糖的相关系数,FMN与餐后血糖的相关系数也高于HbA1c与餐后血糖的相关系数。结论果糖胺与HbA1c相比有一定的优势,可作为监测糖尿病患者血糖控制的良好指标。 Objective To investigate the association among fructosamine(FMN) and blood glucose,glycated hemoglobin(HbA1c).Methods From May 2009 to April 2009,75 diabetes and 36 health subjects were recruited for this study.Blood samples was collected and assayed for FMN,HbA1C,and fasting glucose.The 2-hour oral glucose tolerance test (OGTT-2h)was given.Results Fasting glucose,OGTT-2h glucose,FMN and HbA1c were all higher in diabetes group than in healthy control group (P0.05).There was positive correlation between FMN and fasting glucose,OGTT-2h glucose,and HbA1c(P0.05).The correlation coefficients between FMN and glucose were higher than those between HbA1c and glucose.Conclusion Compared with HbA1c,FMN has advantage in monitoring blood glucose in diabetes and be regarded as a suitable index for blood glucose control.
作者 余霆 黄志刚
出处 《华西医学》 CAS 2010年第7期1325-1327,共3页 West China Medical Journal
关键词 果糖胺 糖尿病 血糖 糖化血红蛋白 Fructosamine Diabetes Blood glucose Glycosylated hemoglobin
  • 相关文献

参考文献12

  • 1贾伟平.血糖控制达标是预防糖尿病并发症的关键[J].上海医学,2005,28(1):1-3. 被引量:46
  • 2Kimberly MM, Vesper HW, Caudill SP, et al. Variability among five over-the-counter blood glucose monitors[J]. Clinica Chimica Acta,2006,364(1 2):292-297.
  • 3Kendall DM, Kaplan RA, Paulson CF, et al. Accuracy and utility of a 10-test disk blood glucose meter[J]. Diabetes Res Clini Practice,2005,67(1):29 35.
  • 4Parramon M. Easier and more comfortable measurement of capillary glycemia: the objective of a new electrochemical coulometric device "'freestyle papillon mini"[J]. Revista de Enfermeria. 2005, 28(9) : 53-56.
  • 5Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self monitoring blood glucose and hemoglobin Alc[J], JAMA,2006,295(14) : 1688-1697.
  • 6Taylor JR,Campbell KM. Home monitoring of glucose and blood pressure[J]. Am Faro Physician, 2007,76 (2) : 255-260.
  • 7Renard E. Monitoring glycemic control: the importance of self- monitoring of blood glucose[J]. Am J Med, 2005, 118 (Suppl 9A) : 12S-19S.
  • 8Klonoff DC. Serum fructosamine as a screening test for type 2 di abetes[J]. Diabetes Technol Ther, 2000,2 (4) : 537-539.
  • 9Lindsey CC, Carter AW, Mangum S, et al. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care [J]. Diabetes Technol Ther, 2004,6 (3) : 637-642.
  • 10Misciagna G, I.ogroscino G, De Miehele G, et al. Fructosamine, glycated hemoglobin, and dietary carbohydrates[J]. Clin Chim Acta,2004,340(1-2):139-147.

二级参考文献34

  • 1贾伟平,于浩泳,项坤三.胰岛素脉冲样分泌的意义及临床应用[J].中华内分泌代谢杂志,2004,20(4). 被引量:6
  • 2潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量:193
  • 3姜素英,左玉华,张和平,徐文,刘芳,贾伟平.社区糖尿病治疗达标现状分析[J].上海医学,2005,28(1):30-32. 被引量:31
  • 4卫生部疾病控制司 中华医学会糖尿病学分会.中国糖尿病防治指南[Z].,2003.4-6.
  • 5DCCT Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in IDDM. N Engl J Med, 1993, 329: 977-987.
  • 6The diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med, 2000,342:381- 389.
  • 7Nathan DM, l.achin J,Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med, 2003,348: 2294-2303.
  • 8UKPAD Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventiional treatment and risk of complications in patients with type 2 diabetes(UKPDS33). Lancet, 1998, 352:837-853.
  • 9Stevens RJ, Coleman RI., Adler AI, et al. Risk factors for myocardial infarction case falality and stroke case fatality in type 2 diabetes. Diabetes Care, 2004, 27: 201-207.
  • 10Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care, 1999, 22: 920-924.

共引文献116

同被引文献41

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部